Abstract:Context: Diabetic nephropathy (DN) is a common microvascular complication in diabetic patients. The pathogenesis of DN is complex. Inflammatory response may play a key role as a common downstream pathway. Objective: The study intended to explore the relationship between the levels of plasma nucleotide-binding oligomeric domain-like receptor protein 3 (NLRP3 inflammasome), interleukin-1β (IL-1β), and IL-18 and the progression of type 2 diabetic nephropathy to clarify their relationship with type 2 diabetes mellitus (T2DM) and to provide evidence for clinical treatment. Design: The research team performed a controlled observational study. Setting: The study took place at Baoding No. 1 Central Hospital in Baoding, Hebei, China. Participants: Participants were 153 patients with T2DM who received treatment at the hospital between October 2020 and October 2021. The research team allocated 30 participants without evidence of DN to the control group. Based on the DN stage, the team assigned the 123 remaining participants to one of five observation groups: (1) 32 participants with stage 1 DN to the DN1 group, (2) 31 participants with stage 2 DN to the DN2 group, (3) 30 participants with stage 3 DN to the DN3 group, (4) 30 participants with stage 4 DN to the DN4 group, and (5) 29 participants with stage 5 DN to the DN5 group. Outcome measures: The research team measured participants' levels of "nucleotide binding oligomeric domain-like receptor protein 3" (NLRP3), interleukin-1 beta (IL-1β), and IL-18 and used the Spearman rank correlation analysis to determine the correlation between those levels and the DN stages. Results: The levels of NLRP3 , IL-1β and IL-18 in all the five observation groups were significantly higher than those in the control group (all P < .01). The levels were also significantly higher: (1) in the DN2, DN3, DN4, and DN5 groups than those in the DN1 group (all P < .01); (2) in the DN3, DN4, and DN5 groups than those in the DN2 group (all P < .01); (3) in the DN4 and DN5 groups than those in the DN3 group (all P < .01); and (4) in the DN5 groups than those in the DN4 group (all P < .01). The Spearman rank correlation analysis showed that the NLRP3, IL-1β, and IL-18 levels were significantly positively correlated with the DN stage (P = .01). Conclusions: NLRP3, IL-1β and IL-18 played an important role in the progression of T2DM, and their levels increased with the aggravation of DN. Therefore, the plasma levels of NLRP3, IL-1β and IL-18 can be useful as indicators of the occurrence and development of DN and can provide clinical guidance for the early diagnosis of DN and for the determination and adjustment of treatment plans.

The levels of endothelin-1 and nitric oxide in diabetic nephropathy patients

Detection of TNF-α,IL-18 and ADPN in Type 2 Diabetic Patients with Nephropathy

The role of serum nitric oxide and platelet activation abnormity in diabetic nephropathy

TNF-? and IL-1? Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters

The relationship between plasma endothelin/nitric oxide and di abetic retinopathy

Evaluation of levels of nitric oxide and endothelin in type 2 diabetes patients with an-giopathy

Clinical Analysis on Changes of Nitric Oxide(no),endothelin(et),thromboxane A2 and Prostaglandin I2 in Type 2 Diabetic Nephropathy

Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy

[Study on the Relationship Between Plasma Endothelin Nitric Oxide Concentration and Renal Hypertension and Renal Function].

Correlation Between Plasma NLRP3, IL-1β, and IL-18 and Diabetic Nephropathy in Patients With Type 2 Diabetes

A review of endothelial nitric oxide synthase and diabetic nephropathy

Serum Remnant-Like Particle Cholesterol Concentration and Its Clinical Significance in the Patients with Type 2 Diabetes Mellitus

Elevated ACE Levels Indicate Diabetic Nephropathy Progression or Companied Retina Impaired

Relationship Between Renal Nitric Oxide and Glomerular Hyper Filtration in Experimental Diabetic Rats

Altered Expression of Vascular Endothelial Growth Factor and Its Receptor in the Kidneys of Patients with Type 2 Diabetic Bnephropathy

Assessment of Urinary Endothelin-1 and Nitric Oxide Levels and Their Relationship with Clinical and Pathologic Types in Primary Glomerulonephritis.

Relationship between Serum 1,25-Dihydroxyvitamin D3 and Diabetic Nephropathy

Significance of Serum Adiponectin in Type 2 Diabetic Patients with Nephropathy

Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy

The study of endothelins and calcitonin gene-related peptide in type 2 diabetes mellitus

The Wnt Signaling Pathway in Diabetic Nephropathy